We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.
S&P Futures
5,176.00 +8.50 (+0.16%) Dow Futures
38,292.00 +54.00 (+0.14%) Nasdaq Futures
18,215.00 +35.75 (+0.20%) Russell 2000 Futures
2,028.80 +9.00 (+0.45%) Crude Oil
85.43 -0.23 (-0.27%) Gold
2,373.20 -0.90 (-0.04%)
Siemens Healthineers AG (SEMHF)
Chart Events
Performance Outlook
| Previous Close | 60.19 |
| Open | 56.73 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 56.73 - 57.47 |
| 52 Week Range | 47.99 - 63.19 |
| Volume | |
| Avg. Volume | 454 |
| Market Cap | 64.717B |
| Beta (5Y Monthly) | 0.73 |
| PE Ratio (TTM) | 39.63 |
| EPS (TTM) | 1.45 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.02 (1.77%) |
| Ex-Dividend Date | Apr 19, 2024 |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for SEMHF
Related Research
- SIEMENS HEALTHINEERS AGAnalyst Report: Merck KGaAMerck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (44% of 2023 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (38%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (17%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.RatingFair ValueEconomic Moat5 days agoMorningstar
Simply Wall St.Interested In Siemens Healthineers' (ETR:SHL) Upcoming €0.95 Dividend? You Have Four Days Left
It looks like Siemens Healthineers AG ( ETR:SHL ) is about to go ex-dividend in the next 4 days. The ex-dividend date...
- Simply Wall St.
Investing in Siemens Healthineers (ETR:SHL) five years ago would have delivered you a 57% gain
Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...
The Wall Street JournalHeard on the Street: Philips Struggles to Draw a Line Under Its Sleep-Apnea Crisis
Dutch healthcare-equipment maker [Royal Philips just announced a long-awaited deal with U.S. authorities](https://www.wsj.com/business/retail/philips-reaches-agreement-with-fda-over-ventilator-recall-90242fd9) over its scandal-struck sleep-apnea machines. The explanation is that the settlement didn’t bring the kind of clarity on the future of Philips’ respiratory business that investors might have hoped for. Under the terms of a provisional agreement with the Food and Drug Administration, it won’t be allowed to sell its sleep-apnea machines in the U.S. until it meets undisclosed requirements.
Business WireSiemens Healthineers launches Atellica CI Analyzer, compact testing system to tackle lab challenges
TARRYTOWN, N.Y., July 20, 2023--The newest addition to the Siemens Healthineers Atellica in vitro diagnostics portfolio, the Atellica CI Analyzer1 for immunoassay and clinical chemistry testing, has received FDA clearance and is now available in many of the world’s major markets. Labs operating at low to medium testing volumes will benefit from competitive advantages that the analyzer offers, including improved turnaround time predictability, advanced reporting functionality, and focused safety
People Also Watch
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| SMMNY Siemens Healthineers AG | |||
| MKGAF Merck KGaA | |||
| LZAGF Lonza Group AG | |||
| CMXHF CSL Limited | |||
| DSKYF Daiichi Sankyo Company, Limited |
Similar to SEMHF
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| AEMD Aethlon Medical, Inc. | |||
| SNN Smith & Nephew plc | |||
| PEN Penumbra, Inc. | |||
| BIOL BIOLASE, Inc. | |||
| EW Edwards Lifesciences Corporation |
Upgrades & Downgrades
| Initiated | Societe Generale: to Buy | 7/23/2021 |
Company Profile
Siemensstr. 3
Forchheim 91301
Germany
49 9131 84 3385
https://www.siemens-healthineers.com
Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 71,400
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthhcare consulting, products, and services. The company is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
